Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023836
Filing Date
2025-05-08
Accepted
2025-05-08 16:21:37
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-20250331.htm   iXBRL 10-Q 1309084
2 EX-31.1 abcl-20250331xexx311.htm EX-31.1 10406
3 EX-31.2 abcl-20250331xexx312.htm EX-31.2 10369
4 EX-32.1 abcl-20250331xexx321.htm EX-32.1 4766
5 EX-32.2 abcl-20250331xexx322.htm EX-32.2 4743
11 abcl-20250331_g1.jpg GRAPHIC 200524
  Complete submission text file 0001628280-25-023836.txt   5901262

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20250331.xsd EX-101.SCH 37684
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abcl-20250331_cal.xml EX-101.CAL 60457
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20250331_def.xml EX-101.DEF 157344
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20250331_lab.xml EX-101.LAB 510921
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20250331_pre.xml EX-101.PRE 340272
74 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20250331_htm.xml XML 542985
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 25926563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)